Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2002
12/05/2002US20020183512 Compounds for use in treatment of cancer
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183391 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
12/05/2002US20020183386 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/05/2002CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002CA2443346A1 Anticholinergic compounds and methods of use
12/05/2002CA2442212A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
12/04/2002EP1262473A1 Precursors for fragrant ketones and fragrant aldehydes
12/04/2002EP1100769B1 Aminomethylcarboxylic acid derivatives
12/04/2002CN1383423A 6-fluorobicyclo [3.1.0] hexame derivatives
12/04/2002CN1382685A Process for preparing R-salbutamol tartrate
12/03/2002US6489479 Process for the preparation of mixed anhydrides
12/03/2002US6489352 Antiepileptic agents; nervous system disorders
11/2002
11/28/2002WO2002095393A2 Drug evolution: drug design at hot spots
11/28/2002WO2002062871A3 Comonomer compositions for production of imide-containing polyamino acids
11/28/2002US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002DE10125451A1 New N-benzyl-m-phenylenediamine derivatives and physiologically-compatible, water-soluble salts are used in oxidative colorant for keratin fibers, especially human hair
11/27/2002EP1260511A1 Process for the preparation of 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and method of manufacturing sertindole
11/27/2002EP1260270A1 Preparation and use of palladium catalysts for cross coupling reactions
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
11/27/2002CN1382118A Biocyclic amino acids aspharmaceutical agents
11/26/2002US6485799 Aniline derivatives, liquid-crystal composition containing the same, and liquid-crystal display element
11/26/2002US6485629 Process for separation of heavy metals from residues by use of ethylene-diamine-disuccinic acid (edds) complexant
11/26/2002CA2130333C Process for preparing .beta.-phenylisoserine and analogues thereof
11/26/2002CA2060330C Compositions and method for soft tissue tumors
11/24/2002CA2354921A1 Drug evolution: drug design at hot spots
11/21/2002WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
11/21/2002US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002US20020173421 Cross-coupling reaction using palladium complex catalyst
11/21/2002DE10123884A1 Preparation of palladium catalyst solution or dispersion involves reacting chloro-, bromo- or iodo-aromatic or aryl sulfonate, phosphine or diphosphine ligand and palladium salt
11/21/2002CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/20/2002EP1257541A2 Polypharmacophoric agents
11/20/2002EP1257524A1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid
11/20/2002EP1257523A1 Method of producing 3-aminoalkanoic acid esters
11/20/2002EP0721936B1 Liquid softener composition and quaternary ammonium salt
11/19/2002US6482943 Quinones as disease therapies
11/19/2002US6482855 Oxidation resistance; stress relieving
11/19/2002US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002CA2243544C 7-amino-2-heptenoates and their use in the preparation of methylphenidate
11/14/2002WO2002090318A1 Process for preparing bicyclic amino acids
11/14/2002WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169311 Generation of betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids or mixtures; obtain mixture, apply to chromatographic column, elute preferential products form column
11/14/2002US20020169208 Oxybutynin analogs; antichloinergic agents; side effect reduction; short half-life; water-soluble metabolites; incontinence; mydriatic and bronchodilator agents; respiratory system disorders; antiperspirants
11/14/2002US20020169197 Diaryl-enynes
11/14/2002US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002US20020168244 Locking nut, bolt and clip systems and assemblies
11/13/2002EP1256568A1 Intermediates for the preparation of enantiomerically pure cyclopentane and cyclopentene beta amino acids
11/13/2002EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002EP1255733A1 Farnesyl transferase inhibitors
11/13/2002EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002CN1379779A Process for preparation of benzoxazine derivatives and intermediates therefor
11/13/2002CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/12/2002US6479700 Method for separating a basic amino acid from fermentation broth
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002WO2002088068A1 Aminoacid-iodine complex
11/07/2002WO2002088061A1 Novel atisane compound and use thereof
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002WO2001042243A3 Protein kinase inhibitors
11/07/2002US20020165408 Industrial process for the production of L-carnitine
11/07/2002US20020165282 PPAR agonists
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165200 Central nervous system disorders
11/06/2002EP1254883A1 Process for producing sobstituted 1,1,1-trifluoro-3-butene-2-ones
11/06/2002EP1254092A1 Resolution of dl-racemic mixtures
11/06/2002EP1124788A4 Bis(haloethyl)aminobenzene derivatives
11/06/2002EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002EP1002020B1 Dye intermediate and method to manufacture dyes
11/06/2002EP0975582B1 Preparation and use of iminodisuccinic acid salts
11/06/2002EP0923528B1 Oligosaccharide synthesis
11/06/2002EP0788473B1 Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-beta-amino acids
11/06/2002CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/06/2002CN1093853C New method for preparing (S)-4-amino-hepta-5,6-dienoic acid and intermediate thereof
11/06/2002CN1093755C Topical composition for inhibiting hair growth
11/05/2002US6476243 Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
10/2002
10/31/2002WO2002085877A2 Processes and intermediates for preparing benzyl substituted epoxides
10/31/2002WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002US20020161259 Catalyst comprising: a metal support comprising copper and a non-copper metal; and a copper-containing coating in specified amounts of copper; making N-(phosphonomethyl)glycine from monoethanolamine
10/31/2002US20020161238 Novel methods for the preparation of taxanes using oxazolidine intermediates
10/31/2002US20020161171 Comonomer compositions for production of imide-containing polyamino acids
10/31/2002US20020161047 Method for preventing and treating visceral pain and gastrointestinal disorders
10/31/2002US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula
10/31/2002US20020158020 Process for the separation of organic substances from an aqueous mixture
10/31/2002CA2445163A1 Processes and intermediates for preparing benzyl substituted epoxides
10/30/2002EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same
10/30/2002EP1252133A2 Pharmaceutical compounds